Laurent Mesnard

3.4k total citations
92 papers, 1.8k citations indexed

About

Laurent Mesnard is a scholar working on Nephrology, Immunology and Molecular Biology. According to data from OpenAlex, Laurent Mesnard has authored 92 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Nephrology, 23 papers in Immunology and 19 papers in Molecular Biology. Recurrent topics in Laurent Mesnard's work include Renal Diseases and Glomerulopathies (31 papers), Complement system in diseases (14 papers) and Renal Transplantation Outcomes and Treatments (13 papers). Laurent Mesnard is often cited by papers focused on Renal Diseases and Glomerulopathies (31 papers), Complement system in diseases (14 papers) and Renal Transplantation Outcomes and Treatments (13 papers). Laurent Mesnard collaborates with scholars based in France, United States and Netherlands. Laurent Mesnard's co-authors include Éric Rondeau, Emmanuel Letavernier, Jean‐Philippe Haymann, Sophie Vandermeersch, Laurent Baud, Chantal Jouanneau, Alexandre C. Keller, Alexandre Hertig, Joëlle Perez and Pierre Ronco and has published in prestigious journals such as Nucleic Acids Research, The Journal of Experimental Medicine and Blood.

In The Last Decade

Laurent Mesnard

86 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurent Mesnard France 22 582 435 369 319 254 92 1.8k
Dominique Guerrot France 27 704 1.2× 576 1.3× 361 1.0× 330 1.0× 178 0.7× 103 2.3k
Motoshi Hattori Japan 28 1.4k 2.4× 544 1.3× 314 0.9× 444 1.4× 194 0.8× 186 2.8k
Ana Tobar Israel 22 399 0.7× 645 1.5× 274 0.7× 192 0.6× 229 0.9× 51 2.1k
Klaus Arbeiter Austria 22 557 1.0× 230 0.5× 205 0.6× 174 0.5× 77 0.3× 74 1.3k
M. Arias Spain 27 337 0.6× 312 0.7× 285 0.8× 291 0.9× 610 2.4× 163 2.2k
Licia Peruzzi Italy 29 1.5k 2.6× 525 1.2× 513 1.4× 554 1.7× 132 0.5× 125 2.7k
Eric Rondeau France 22 766 1.3× 350 0.8× 932 2.5× 267 0.8× 175 0.7× 49 2.1k
Kazuho Honda Japan 28 1.8k 3.0× 616 1.4× 359 1.0× 529 1.7× 130 0.5× 166 3.0k
J. A. E. van Wijk Netherlands 29 943 1.6× 720 1.7× 260 0.7× 341 1.1× 170 0.7× 67 2.3k
Kate Wyburn Australia 18 546 0.9× 424 1.0× 637 1.7× 142 0.4× 224 0.9× 79 2.0k

Countries citing papers authored by Laurent Mesnard

Since Specialization
Citations

This map shows the geographic impact of Laurent Mesnard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Mesnard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Mesnard more than expected).

Fields of papers citing papers by Laurent Mesnard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Mesnard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Mesnard. The network helps show where Laurent Mesnard may publish in the future.

Co-authorship network of co-authors of Laurent Mesnard

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Mesnard. A scholar is included among the top collaborators of Laurent Mesnard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Mesnard. Laurent Mesnard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pottier, Nicolas, et al.. (2025). Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome. Nephrology Dialysis Transplantation. 40(8). 1522–1530.
2.
Nguyen, Clément, Nicolas Kuperwasser, Marion Rabant, et al.. (2025). Podocyte-specific YAP activation triggers crescentic glomerulonephritis through cross-talk with parietal epithelial cells. Science Translational Medicine. 17(804). eadq7825–eadq7825. 1 indexed citations
3.
Robert, Thomas, et al.. (2025). CKDx: a necessary step—but can we go further?. Nephrology Dialysis Transplantation. 40(12). 2217–2221.
4.
Lombardi, Yannis, et al.. (2024). Challenging the narrative of Alport syndrome spectrum: no link with cystic phenotype. Nephrology Dialysis Transplantation. 40(7). 1408–1415. 2 indexed citations
5.
Scemla, Anne, Magali Giral, Nadia Arzouk, et al.. (2024). Use of a Belatacept-based Immunosuppression for Kidney Transplantation From Donors After Circulatory Death: A Paired Kidney Analysis. Transplantation Direct. 10(5). e1615–e1615. 1 indexed citations
6.
Fakhouri, Fádi, Yahsou Delmas, Sophie Caillard, et al.. (2024). Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic Syndrome. American Journal of Kidney Diseases. 84(2). 244–249. 3 indexed citations
7.
Joseph, Adrien, Stéphanie Harel, Laurent Mesnard, et al.. (2024). Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes. Nephrology Dialysis Transplantation. 39(12). 2067–2078. 4 indexed citations
8.
Robert, Thomas, et al.. (2024). Systematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease–MUC1 27dupC Pathogenic Variant through Exome Sequencing. Journal of the American Society of Nephrology. 36(2). 256–263. 3 indexed citations
9.
Mesnard, Laurent, et al.. (2023). #6812 ON THE TOP PHARMACOGENETICS STUDY EXTRACTED FROM EXOME SEQUENCING DONE FOR CHRONIC KIDNEY DISEASES OF UNKNOW ORIGIN. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations
10.
11.
Yousfi, Nadhir, et al.. (2023). The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases. European Journal of Human Genetics. 31(7). 730–732. 2 indexed citations
12.
Dunand, Olivier, et al.. (2022). Bi‐allelic pathogenic variants in ITGA8 cause slowly progressive renal disease of unknown etiology. Clinical Genetics. 103(1). 114–118. 4 indexed citations
13.
Orieux, Arthur, Liliana Pâslaru, Marine Livrozet, et al.. (2022). Predictive factors of glomerular filtration rate loss associated with living kidney donation: a single-center retrospective study. World Journal of Urology. 40(9). 2161–2168. 3 indexed citations
14.
Chung, Hyunjae, Takanori Komada, Arthur Lau, et al.. (2021). AIM2 Suppresses Inflammation and Epithelial Cell Proliferation during Glomerulonephritis. The Journal of Immunology. 207(11). 2799–2812. 11 indexed citations
15.
Estève, Emmanuel, Emmanuelle Plaisier, Catherine Johanet, et al.. (2019). Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD. Kidney International Reports. 5(3). 331–338. 28 indexed citations
16.
Luque, Yosu, Olivia Lenoir, Philippe Bonnin, et al.. (2017). Endothelial Epas1 Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension. Journal of the American Society of Nephrology. 28(12). 3563–3578. 18 indexed citations
17.
Mesnard, Laurent, Dominique Cathelin, Sophie Vandermeersch, et al.. (2014). Genetic Background–Dependent Thrombotic Microangiopathy Is Related to Vascular Endothelial Growth Factor Receptor 2 Signaling during Anti-Glomerular Basement Membrane Glomerulonephritis in Mice. American Journal Of Pathology. 184(9). 2438–2449. 9 indexed citations
18.
Dêbiec, Hanna, Laurent Martin, Chantal Jouanneau, et al.. (2011). Autoantibodies Specific for the Phospholipase A2 Receptor in Recurrent and De Novo Membranous Nephropathy. American Journal of Transplantation. 11(10). 2144–2152. 103 indexed citations
19.
Michel, P.A., Karine Dahan, Pierre‐Yves Ancel, et al.. (2011). Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients. PubMed. 1(1). 251–261. 19 indexed citations
20.
Rafat, Cédric, Sophie Vimont, Pierre‐Yves Ancel, et al.. (2011). Ofloxacin: new applications for the prevention of urinary tract infections in renal graft recipients. Transplant Infectious Disease. 13(4). 344–352. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominique Guerrot Breakdown of academic impact, for papers by Motoshi Hattori Breakdown of academic impact, for papers by Ana Tobar Breakdown of academic impact, for papers by Klaus Arbeiter Breakdown of academic impact, for papers by M. Arias Breakdown of academic impact, for papers by Licia Peruzzi Breakdown of academic impact, for papers by Eric Rondeau Breakdown of academic impact, for papers by Kazuho Honda Breakdown of academic impact, for papers by J. A. E. van Wijk Breakdown of academic impact, for papers by Kate Wyburn
Rankless by CCL
2026